Liver cirrhosis trials in China

In China 75 Also abroad 358

75 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Risk Assessment for HBV-Related Liver Cancer
Where
Guangzhou
Age
30 years to 75 years
People
6,000
Run by
Sun Yat-sen University
See details and how to joinNCT07160946
No phaseTaking people
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
Where
Hengyang
Age
18 years to 75 years
People
800
Run by
The First Affiliated Hospital of University of South China
See details and how to joinNCT07147335
No phaseTaking people
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
Where
Shenyang
Age
18 years and over
People
174
Run by
General Hospital of Shenyang Military Region
See details and how to joinNCT06483737
No phaseTaking people
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
Where
Guangzhou, Shanghai
Age
18 years and over
People
375 worldwide
Run by
Chinese University of Hong Kong
See details and how to joinNCT06549673
No phaseTaking people
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
Where
Yangzhou
Age
18 years and over
People
5
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT05433467
No phaseNot yet taking people in China
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
Where
Beijing, Changsha, Changzhi, Foshan, Fuzhou, Guangzhou, Guiyang, Jincheng, Jinzhong, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shiyan, Taiyuan, Zhuhai
Age
18 years to 75 years
People
735
Run by
Beijing Friendship Hospital
See details and how to joinNCT07087041
No phaseNot yet taking people in China
Prognostic Model for MASLD Related Cirrhosis
Where
Beijing, Tianjin
Age
18 years to 80 years
People
228
Run by
Beijing Friendship Hospital
See details and how to joinNCT07082751
No phaseTaking people
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Where
Xi'an
Age
18 years to 70 years
People
1,500
Run by
First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT07079150
Phase 1/2Taking people
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Where
Beijing
Age
16 years to 85 years
People
90
Run by
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053488
No phaseTaking people
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
Where
Chongqing
Age
18 years to 75 years
People
300
Run by
Juan Kang
See details and how to joinNCT06328517
No phaseTaking people
Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis
Where
Chongqing
Age
18 years to 75 years
People
300
Run by
Juan Kang
See details and how to joinNCT07031843
No phaseTaking people
The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
Where
Yangzhou
Age
18 years and over
People
20
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT05325424
No phaseTaking people
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients
Where
Yangzhou
Age
18 years and over
People
20
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT05325437
No phaseEnrolling by invitation
Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic Experiment
Where
Beijing
Age
18 years and over
People
700
Run by
Beijing YouAn Hospital
See details and how to joinNCT06995846
No phaseTaking people
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients
Where
Yangzhou
Age
18 years and over
People
20
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT05338294
No phaseTaking people
Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air
Where
Shanghai
Age
18 years and over
People
1,000
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT06968234
No phaseEnrolling by invitation
Evaluation of Endoscopic Treatment Effect Based on HVPG
Where
Hangzhou
Age
18 years to 80 years
People
50
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06863519
No phaseTaking people
Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.
Where
Chongqing
Age
18 years to 70 years
People
330
Run by
The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06293378
No phaseNot yet taking people in China
AI-guided TIPS Procedure
Where
Wuhan
Age
18 years to 80 years
People
180
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06837974
No phaseNot yet taking people in China
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
Where
Beijing
Age
18 years to 75 years
People
195
Run by
Beijing Friendship Hospital
See details and how to joinNCT06773221
No phaseEnrolling by invitation
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
Where
Guangzhou
Age
18 years to 80 years
People
2,334
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06741904
Phase 1Enrolling by invitation
A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis
Where
Hefei
Age
18 years to 75 years
People
9
Run by
Anhui Provincial Hospital
See details and how to joinNCT06671275
Phase 2Taking people
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
Where
Beijing, Guangzhou, Kashgar, Lanzhou, Sanya, Shanghai, Wuhan
Age
18 years to 75 years
People
140
Run by
Beijing 302 Hospital
See details and how to joinNCT05224960
No phaseTaking people
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
Where
Zhuhai
Age
18 years and over
People
1,200
Run by
Fifth Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06060769
No phaseTaking people
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Where
Shanghai
Age
18 years to 75 years
People
20,000
Run by
Ruijin Hospital
See details and how to joinNCT05870969